BridgeBio inks $250M PIPE two months after PhIII heart pill win, hints at more financing - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
BridgeBio will gain about $250 million via a private investment as the biotech nears an approval submission for its heart pill, two months after initially disclosing a topline win that sent shares skyrocketing about 50%. The Palo Alto, CA-based biotech said t…